paediatrics Brussels 17

My objectives are to:

• To consider mechanisms of brain injury and their impact on patient quality of life as a basis for designing strategies to reduce brain injury.

• To consider new drug developments and the associated challenges of delivering precision medicine to clinical practice.

• To add the priority of delivery systems designed to optmize delivery of drugs to CNS tumours as a priority for future clinical practice.